These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11936126)

  • 1. Nephrectomy for metastatic renal-cell cancer.
    Copur MS; Ledakis P; Norvell M
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936126
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrectomy for metastatic renal-cell cancer.
    Polo JL
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936124
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrectomy for metastatic renal-cell cancer.
    Bolger G
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11932483
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.
    Pantuck AJ; Belldegrun AS; Figlin RA
    N Engl J Med; 2001 Dec; 345(23):1711-2. PubMed ID: 11759660
    [No Abstract]   [Full Text] [Related]  

  • 5. Removing the primary tumor after the cancer has spread.
    Tannock IF
    N Engl J Med; 2001 Dec; 345(23):1699-700. PubMed ID: 11759650
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrectomy for metastatic renal-cell cancer.
    Schwartz JD
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936125
    [No Abstract]   [Full Text] [Related]  

  • 8. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
    Kirkali Z
    Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
    Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon in metastatic renal cell carcinoma.
    Fosså SD
    Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
    Flanigan RC; Salmon SE; Blumenstein BA; Bearman SI; Roy V; McGrath PC; Caton JR; Munshi N; Crawford ED
    N Engl J Med; 2001 Dec; 345(23):1655-9. PubMed ID: 11759643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive nephrectomy in metastatic renal cancer.
    Flanigan RC
    Curr Urol Rep; 2003 Feb; 4(1):36-40. PubMed ID: 12537937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful cumulative treatment with pre/post-operative interferon-alpha, nephrectomy, and surgical resection of metastasis in advanced renal cell carcinoma : a case report].
    Hisamatsu H; Yamashita S
    Hinyokika Kiyo; 2010 Mar; 56(3):155-8. PubMed ID: 20372043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.
    Rini BI; Shaw V; Rosenberg JE; Kim ST; Chen I
    Clin Genitourin Cancer; 2006 Dec; 5(3):232-4. PubMed ID: 17239278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
    Mickisch GH; Garin A; van Poppel H; de Prijck L; Sylvester R;
    Lancet; 2001 Sep; 358(9286):966-70. PubMed ID: 11583750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephrectomy: past, present and future.
    Galazi M; Rodriguez-Vida A; Josephides E; Chau NM; Chowdhury S
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):271-7. PubMed ID: 24392671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma].
    Miller K; Bergmann L; Albers P; Jäger E; Jakse G; Geschwend JE; Marschner N
    Aktuelle Urol; 2007 Jul; 38(4):328-30. PubMed ID: 17647172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of renal cell carcinoma in childhood].
    Nakayama Y; Yasuno H; Okamoto M; Itani A
    Hinyokika Kiyo; 1992 Sep; 38(9):1055-8. PubMed ID: 1414759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel investigative approaches for advanced renal cell carcinoma.
    Berg WJ; Divgi CR; Nanus DM; Motzer RJ
    Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.